XTX Topco Ltd trimmed its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 71.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,161 shares of the company's stock after selling 17,587 shares during the period. XTX Topco Ltd's holdings in Azenta were worth $358,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Picton Mahoney Asset Management raised its holdings in shares of Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares during the period. Headlands Technologies LLC acquired a new stake in Azenta during the 4th quarter worth approximately $40,000. Covestor Ltd raised its holdings in Azenta by 64.2% in the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock valued at $102,000 after buying an additional 799 shares during the period. KBC Group NV lifted its position in Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares in the last quarter. Finally, Sterling Capital Management LLC grew its stake in Azenta by 39.8% during the fourth quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock worth $143,000 after buying an additional 813 shares during the period. 99.08% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on AZTA shares. Evercore ISI lifted their target price on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Needham & Company LLC boosted their price objective on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research note on Thursday, February 6th. Stephens reiterated an "overweight" rating and issued a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. Finally, TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th.
Check Out Our Latest Report on Azenta
Azenta Trading Down 1.5 %
NASDAQ:AZTA traded down $0.40 on Friday, reaching $26.73. The stock had a trading volume of 603,236 shares, compared to its average volume of 648,004. Azenta, Inc. has a 12-month low of $24.06 and a 12-month high of $63.58. The stock has a market cap of $1.22 billion, a P/E ratio of -8.97 and a beta of 1.66. The company has a 50-day moving average of $35.03 and a 200 day moving average of $43.25.
Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, equities analysts predict that Azenta, Inc. will post 0.53 EPS for the current year.
Azenta Profile
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Stories

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.